Stephen P. Squinto's Insider Trades & SAST Disclosures
Stephen P. Squinto's most recent trade in SpringWorks Therapeutics Inc was a trade of 15,318 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 19, 2022.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Stephen P. Squinto.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| SpringWorks Therapeutics Inc | Stephen P. Squinto | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 15,318 | 15,318 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | Stephen P. Squinto | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 4,818 | 131,652 (0%) | 0% | 0 | Common Stock | |
| Compass Therapeutics Inc | Stephen P. Squinto | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | Stephen P. Squinto | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 6,998 | 6,998 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | Stephen P. Squinto | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 1,106 | 126,834 (0%) | 0% | 0 | Common Stock | |
| SpringWorks Therapeutics Inc | Stephen P. Squinto | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 76.20 per share. | 27 Apr 2021 | 19,231 | 125,728 (0%) | 0% | 76.2 | 1,465,437 | Common Stock |
| SpringWorks Therapeutics Inc | Stephen P. Squinto | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 75.05 per share. | 27 Apr 2021 | 201 | 144,959 (0%) | 0% | 75.0 | 15,085 | Common Stock |
| SpringWorks Therapeutics Inc | Stephen P. Squinto | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 75.02 per share. | 14 Apr 2021 | 1,057 | 145,160 (0%) | 0% | 75.0 | 79,291 | Common Stock |
| SpringWorks Therapeutics Inc | Stephen P. Squinto | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 75.08 per share. | 14 Apr 2021 | 511 | 146,217 (0%) | 0% | 75.1 | 38,365 | Common Stock |
| SpringWorks Therapeutics Inc | Stephen P. Squinto | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2020 | 7,464 | 7,464 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges